Global Livestock Internal Dewormer Market Size By Type (Tablet, Powder), By Application (Cattle, Equine), By Region, And Segment Forecasts, 2023 to 2032

The Global Livestock Internal Dewormer Market was valued at USD 2.3 billion in 2023 and is projected to reach USD 3.9 billion by 2031, growing at a CAGR of 6.8% during the forecast period from 2023 to 2031. This growth is driven by the increasing global livestock population, heightened awareness around animal health, and the expanding meat and dairy industry. Internal dewormers are essential in improving livestock productivity by preventing parasitic infections that lead to reduced weight gain, lower milk yield, and overall poor animal health. The rising demand for high-quality animal-derived food products and the need to minimize losses associated with parasitic diseases are propelling the market forward.

Drivers:

Rising Demand for Animal-Based Food Products:

The growing global appetite for meat, dairy, and eggs is driving the demand for healthy livestock, in turn boosting the use of internal dewormers to ensure optimal animal productivity.

Increased Awareness of Animal Health and Welfare:

Farmers and livestock owners are increasingly aware of the economic losses caused by internal parasites. Preventive healthcare through deworming is now widely recognized as essential to maintaining livestock health.

Government Support and Veterinary Health Campaigns:

Supportive policies and awareness campaigns by governments and veterinary organizations are encouraging the adoption of regular deworming programs across developing and developed nations.

Restraints:

Lack of Veterinary Infrastructure in Rural Regions:

In several low-income regions, access to veterinary healthcare and deworming treatments remains limited, hindering market penetration.

Risk of Anthelmintic Resistance:

Excessive or improper use of internal dewormers can lead to parasite resistance, reducing drug efficacy and posing a major challenge for sustainable parasite control.

Opportunity:

Innovation in Dewormer Formulations:

Advancements in delivery mechanisms such as slow-release boluses and injectable solutions are offering new opportunities for market players to differentiate their offerings.

Emerging Livestock Farming in Asia-Pacific and Africa:

The rapid growth of livestock farming in these regions, paired with rising investment in animal healthcare, offers immense potential for market expansion.

Market by System Type Insights:

By system type, the Oral Dewormers segment held the largest market share in 2023. These products are widely preferred due to their ease of administration and cost-effectiveness. However, Injectable Dewormers are gaining popularity, especially in commercial farming operations, due to their higher efficacy and convenience in mass treatment scenarios.

Market by End-use Insights:

In terms of end use, the Cattle Segment was the leading revenue contributor in 2023. Cattle are particularly susceptible to gastrointestinal parasites, which can significantly impact milk and meat yield. The Sheep and Goats Segment is expected to register the fastest growth during the forecast period due to rising small ruminant farming in developing countries.

Market by Regional Insights:

North America dominated the global livestock internal dewormer market in 2023, benefiting from well-established veterinary infrastructure and high awareness levels among livestock owners. However, Asia-Pacific is projected to witness the highest CAGR through 2031, fueled by rapid livestock population growth, increasing government focus on food security, and improving access to veterinary care.

Competitive Scenario:

Prominent companies in the global livestock internal dewormer market include Zoetis Inc., Boehringer Ingelheim, Elanco Animal Health, Merck & Co., Virbac, Ceva Santé Animale, Vetoquinol, Bayer Animal Health, Bimeda, and Norbrook Laboratories. These players are focusing on product innovation, strategic collaborations, and geographic expansion to consolidate their market positions.

Key Market Developments:

2023: Zoetis launched a new long-acting injectable dewormer tailored for beef cattle, designed to reduce reinfection cycles.

2024: Elanco announced a partnership with a tech company to develop a smart livestock monitoring system integrated with parasite management alerts.

2025: Merck introduced a combination dewormer targeting multiple parasite species, improving treatment compliance and effectiveness.

Scope of Work – Global Livestock Internal Dewormer Market

Report Metric Details

Market Size (2023) USD 2.3 billion

Projected Market Size (2031) USD 3.9 billion

CAGR (2023–2031) 6.8%

Key Segments System Type (Oral, Injectable), End-Use (Cattle, Sheep & Goats, Swine, Others)

Growth Drivers Rising animal protein demand, improved livestock healthcare awareness, support from veterinary policies

Opportunities Innovation in dewormer delivery methods, emerging livestock farming in developing nations

FAQs

1. What is the current market size of the Global Livestock Internal Dewormer Market?

The market was valued at USD 2.3 billion in 2023.

2. What is the major growth driver of the Global Livestock Internal Dewormer Market?

The increasing demand for high-quality animal products and enhanced livestock productivity are key growth drivers.

3. Which is the largest region during the forecast period in the Global Livestock Internal Dewormer Market?

North America held the largest share in 2023, while Asia-Pacific is projected to grow at the fastest pace.

4. Which segment accounted for the largest market share in the Global Livestock Internal Dewormer Market?

The Oral Dewormers segment accounted for the largest share in 2023.

5. Who are the key market players in the Global Livestock Internal Dewormer Market?

Key players include Zoetis, Boehringer Ingelheim, Elanco, Merck, Virbac, and Ceva Santé Animale.